Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.124.002165Source: DataRank Database

Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 1.43)OA: bronzeTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Henry Blanton ORCID,Canice Lei Dancel,Isabel Castro‐Piedras ORCID,Boyd R. Rorabaugh ORCID,Daniel J. Morgan ORCID

Live enrichment

PubMed:38936979 PMC:PMC11493449 OpenAlex:https://openalex.org/W4400082715

NIDA NIH HHS

Grant: R01 DA044999

FWCI

1.43

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttps://jpet.aspetjournals.org/content/jpet/early/2024/06/27/jpet.124.002165.full.pdf

publisherhttps://jpet.aspetjournals.org/content/jpet/early/2024/06/27/jpet.124.002165.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022356524178032?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022356524178032?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/jpet.124.002165

Fields of Study

Cancer Treatment and PharmacologyPain Mechanisms and TreatmentsPharmacological Receptor Mechanisms and EffectsAnimalsFemaleMaleMiceSex CharacteristicsCannabinoidsDrug TolerancePeripheral Nervous System DiseasesCannabinoid Receptor AgonistsAntineoplastic AgentsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2CisplatinGonadal Steroid HormonesMice, Inbred C57BLCyclohexanols

MeSH Terms

AnimalsAntineoplastic AgentsCannabinoidsCisplatinCyclohexanolsDrug ToleranceFemaleMaleMice, Inbred C57BLPeripheral Nervous System DiseasesSex CharacteristicsGonadal Steroid HormonesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2MiceCannabinoid Receptor Agonists

Keywords

Cannabinoid receptorPeripheral neuropathyCannabinoidMedicineInternal medicineEndocrinologyReceptorAgonistDiabetes mellitus

Sustainable Development Goals

SDG 0: Good health and well-being